Back to Search Start Over

RCAN1-4 is a thyroid cancer growth and metastasis suppressor.

Authors :
Wang C
Saji M
Justiniano SE
Yusof AM
Zhang X
Yu L
Fernández S
Wakely P Jr
La Perle K
Nakanishi H
Pohlman N
Ringel MD
Source :
JCI insight [JCI Insight] 2017 Mar 09; Vol. 2 (5), pp. e90651. Date of Electronic Publication: 2017 Mar 09.
Publication Year :
2017

Abstract

Metastasis suppressors are key regulators of tumor growth, invasion, and metastases. Loss of metastasis suppressors has been associated with aggressive tumor behaviors and metastatic progression. We previously showed that regulator of calcineurin 1, isoform 4 (RCAN1-4) was upregulated by the KiSS1 metastatic suppression pathway and could inhibit cell motility when overexpressed in cancer cells. To test the effects of endogenous RCAN1-4 loss on thyroid cancer in vivo, we developed RCAN1-4 knockdown stable cells. Subcutaneous xenograft models demonstrated that RCAN1-4 knockdown promotes tumor growth. Intravenous metastasis models demonstrated that RCAN1-4 loss promotes tumor metastases to the lungs and their subsequent growth. Finally, stable induction of RCAN1-4 expression reduced thyroid cancer cell growth and invasion. Microarray analysis predicted that nuclear factor, erythroid 2-like 3 (NFE2L3) was a pivotal downstream effector of RCAN1-4. NFE2L3 overexpression was shown to be necessary for RCAN1-4-mediated enhanced growth and invasiveness and NEF2L3 overexpression independently increased cell invasion. In human samples, NFE2L3 was overexpressed in TCGA thyroid cancer samples versus normal tissues and NFE2L3 overexpression was demonstrated in distant metastasis samples from thyroid cancer patients. In conclusion, we provide the first evidence to our knowledge that RCAN1-4 is a growth and metastasis suppressor in vivo and that it functions in part through NFE2L3.<br />Competing Interests: Conflict of interest: The authors have declared that no conflict of interest exists.

Details

Language :
English
ISSN :
2379-3708
Volume :
2
Issue :
5
Database :
MEDLINE
Journal :
JCI insight
Publication Type :
Academic Journal
Accession number :
28289712
Full Text :
https://doi.org/10.1172/jci.insight.90651